Viking Therapeutics, Inc. Profile Avatar - Palmy Investing

Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selec…

Biotechnology
US, San Diego [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of VKTX's Analysis
CIK: 1607678 CUSIP: 92686J106 ISIN: US92686J1060 LEI: - UEI: -
Secondary Listings
VKTX has no secondary listings inside our databases.